| Literature DB >> 23903055 |
Jin-E Zhang1, Dan Luo, Rong-Yi Chen, Yan-Ping Yang, Ying Zhou, Yi-Ming Fan.
Abstract
Qualitative measurement of the infective level is relatively difficult in experimental vaginal candidiasis. Female BALB/c mice aged 8 to 10 weeks were randomly divided into E1, E2 and E0 groups, which received subcutaneous injection of 0.05 mg, 0.1 mg of estradiol benzoate or 0.1 ml soybean oil 3 days before vaginal inoculation, respectively, and hormone treatment continued every other day thereafter. Each group was further divided into infected and noninfected subgroups. The infected mice were inoculated intravaginally with 10 μl (5 × 10(4) conidia) of Candida albicans suspension, while the noninfected mice were inoculated with 10 μl phosphate-buffered saline. Direct microscopic examination, colony count and vaginal histopathology including infection degree and inflammation extent were performed at 3, 7 and 14 days post inoculation. Estrogen treatment increased the vaginal fungal burden and extent of infection and inflammation compared with the control group, and 0.3 mg/week estrogen generally induced more severe infection and inflammation than 0.15 mg/week estrogen did. Colony count peaked on day 3 and decreased remarkably after 7 days. Infection score increased gradually during the first 7 days and decreased on day 14, while inflammation extent exacerbated progressively over the course of 14 days. This study demonstrates that the modified histological scoring system might be more feasible than colony count for evaluation of infectivity and dynamic change in experimental vaginal candidiasis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23903055 PMCID: PMC4160942 DOI: 10.1538/expanim.62.205
Source DB: PubMed Journal: Exp Anim ISSN: 0007-5124
Animal grouping and subcutaneous injection dose of estrogen
| Groups | Estrogen* | ||
|---|---|---|---|
| 0 | 0.05 mg | 0.1 mg | |
| Non-infection | E0n | E1n | E2n |
| Infection | E0i | E1i | E2i |
*Estrogen treatment given on alternate days.
Effect of estrogen dose on vaginal fungal burden
| Groups | CFU (104/ml) | ||
|---|---|---|---|
| 3 d | 7 d | 14 d | |
| E0i | 0.73* | 0 | 0 |
| E1i | 6.81 ± 0.06 | 1.57 ± 0.03† | 0.13 ± 0.01†‡ |
| E2i | 9.81 ± 0.06a | 3.43 ± 0.11a† | 0.32 ± 0.01a†‡ |
Data are presented as means ± SEM. *Statistical analysis was not performed because only one animal was positive. aP<0.05 when compared with the E1i group at the same time points. †P<0.05 when compared with day 3. ‡P<0.05 when compared with day 7.
Fig. 1.Infection and inflammation extent in vaginal histopathology (PAS stain, 400×). (a) Numerous pseudohyphae and blastoconidia (black arrow) adhered to the cornified epithelium in the E2i group at 3 dpi (infection degree, score=3; inflammation extent, score=1). (b) Pseudohyphae and blastoconidia (black arrow) adhered to the cornified epithelium, and endocytosed hyphae (white arrows) and neutrophil (N) infiltration in the mucosa in the E2i group at 7 dpi (infection degree, score=3; inflammation extent, score=2). (c) Subcorneal microabscesses (MA), neutrophil (N) infiltration and endocytosed hyphae (white arrows) in the mucosa in the E2i group at 14 dpi (infection degree, score=3; inflammation extent, score=3). (d) Intact mucosa without neutrophil infiltration and hyphal invasion in the E2n group at 7 dpi (infection degree, score=0; inflammation extent, score=0).
Effect of estrogen dose on infection degree
| Groups | Infection degree (scores of 0–3) | ||
|---|---|---|---|
| 3 d | 7 d | 14 d | |
| E0i | 0.33 ± 0.16 | 0.39 ± 0.13 | 0.24 ± 0.11 |
| E1i | 1.80 ± 0.15a | 2.56 ± 0.21a† | 2.28 ± 0.12a†‡ |
| E2i | 1.92 ± 0.14a | 2.77 ± 0.17ab† | 2.45 ± 0.23 a†‡ |
Data are presented as means ± SEM. aP<0.05 when compared with the E0i group at the same time points. bP<0.05 when comparing the E1i and E2i groups at the same time points. †P<0.05 when compared with day 3. ‡P<0.05 when compared with day 7.
Effect of estrogen dose on inflammation extent
| Groups | Inflammation extent (scores of 0–3) | ||
|---|---|---|---|
| 3 d | 7 d | 14 d | |
| E0n | 0.11 ± 0.04 | 0.24 ± 0.06 | 0.18 ± 0.07 |
| E0i | 0.26 ± 0.06 | 0.47 ± 0.03a† | 0.53 ± 0.05a† |
| E1n | 0.38 ± 0.09 | 0.47 ± 0.06 | 0.52 ± 0.07† |
| E1i | 1.61 ± 0.12ab | 2.41 ± 0.21ab† | 2.72 ± 0.28ab†‡ |
| E2n | 0.44 ± 0.06 | 0.51 ± 0.07 | 0.75 ± 0.13†‡ |
| E2i | 1.94 ± 0.17abc | 2.56 ± 0.27abc† | 2.81 ± 0.23ab†‡ |
Data are presented as means ± SEM. aP<0.05 when comparing the infection and non-infection groups at the same time points. bP<0.05 when compared with the E0i group at the same time points. cP<0.05 when comparing the E1i and E2i groups at the same time points. †P<0.05 when compared with day 3. ‡P<0.05 when compared with day 7.